{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:05:26Z","timestamp":1794549926153,"version":"4.9.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE44-0003"],"award-info":[{"award-number":["ANR-20-CE44-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CE15-0009-01"],"award-info":[{"award-number":["ANR-16-CE15-0009-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-12-BSV3-0005-01"],"award-info":[{"award-number":["ANR-12-BSV3-0005-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-20-CE14-0045"],"award-info":[{"award-number":["ANR-20-CE14-0045"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cyto.2022.155891","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T23:28:23Z","timestamp":1653434903000},"page":"155891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":331,"special_numbering":"C","title":["Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine"],"prefix":"10.1016","volume":"156","author":[{"given":"Corinne","family":"Cayrol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2022.155891_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31C","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2022.155891_b0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/eji.200838575","article-title":"The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production","volume":"39","author":"Bourgeois","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nm.2156","article-title":"Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection","volume":"16","author":"Alves-Filho","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2022.155891_b0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.str.2009.08.009","article-title":"Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors\u2013insight into heterotrimeric IL-1 signaling complexes","volume":"17","author":"Lingel","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.cyto.2022.155891_b0065","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.1308651110","article-title":"Structural insights into the interaction of IL-33 with its receptors","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"510\u201323","key":"10.1016\/j.cyto.2022.155891_b0070","article-title":"IL-1 Family cytokines use distinct molecular mechanisms to signal through their shared co-receptor","volume":"47","author":"Gunther","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2022.155891_b0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.0606854104","article-title":"IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo","volume":"104","author":"Carriere","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0090","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/embor.2008.145","article-title":"Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A\u2013H2B acidic pocket","volume":"9","author":"Roussel","year":"2008","journal-title":"EMBO. Rep."},{"key":"10.1016\/j.cyto.2022.155891_b0095","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0100","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefrancais","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0105","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41598-018-21589-2","article-title":"Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage","volume":"8","author":"Scott","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2022.155891_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.cyto.2022.155891_b0115","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2353\/ajpath.2008.080014","article-title":"Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation","volume":"173","author":"Kuchler","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2022.155891_b0120","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.4049\/jimmunol.1101977","article-title":"Endogenous IL-33 Is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues. in situ analysis using a novel Il-33-LacZ gene trap reporter strain","volume":"188","author":"Pichery","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0125","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/s41467-021-26347-z","article-title":"Asthma-associated genetic variants induce IL33 differential expression through an enhancer-blocking regulatory region","volume":"12","author":"Aneas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0130","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/eji.201041332","article-title":"NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis","volume":"41","author":"Arshad","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity."},{"key":"10.1016\/j.cyto.2022.155891_b0140","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1681\/ASN.2017060650","article-title":"Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin","volume":"29","author":"Ferhat","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"707\u201322","key":"10.1016\/j.cyto.2022.155891_b0145","article-title":"Adventitial stromal cells define group 2 innate lymphoid cell tissue niches","volume":"50","author":"Dahlgren","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744927","article-title":"Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation","volume":"12","author":"Barbier","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0155","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1073\/pnas.1424236112","article-title":"Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0160","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut."},{"issue":"184\u201394","key":"10.1016\/j.cyto.2022.155891_b0165","article-title":"A critical role of IL-33 in experimental allergic rhinitis","volume":"130","author":"Haenuki","year":"2012","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078099","article-title":"IL-33, but Not IL-25, Is Crucial for the Development of House Dust Mite Antigen-Induced Allergic Rhinitis","volume":"8","author":"Nakanishi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2022.155891_b0175","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2015.85","article-title":"Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences","volume":"135","author":"Sundnes","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2022.155891_b0180","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1073\/pnas.1201042109","article-title":"Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice","volume":"109","author":"Yasuda","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0185","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/eji.201242863","article-title":"IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation","volume":"43","author":"Hardman","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0190","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2022.155891_b0195","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/mi.2017.61","article-title":"IL-33 promotes gastrointestinal allergy in a TSLP-independent manner","volume":"11","author":"Han","year":"2018","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0205","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1215418","article-title":"The alarmin interleukin-33 drives protective antiviral CD8 T cell responses","volume":"335","author":"Bonilla","year":"2012","journal-title":"Science."},{"key":"10.1016\/j.cyto.2022.155891_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/eji.201948413","article-title":"Fibroblast-derived IL-33 is dispensable for lymph node homeostasis but critical for CD8 T-cell responses to acute and chronic viral infection","volume":"51","author":"Aparicio-Domingo","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0215","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw3658","article-title":"Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors","volume":"4","author":"Spallanzani","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax0416","article-title":"Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33","volume":"4","author":"Mahlakoiv","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0225","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20190689","article-title":"A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue","volume":"216","author":"Rana","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0230","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1073\/pnas.1922559117","article-title":"Neuronal, stromal, and T-regulatory cell crosstalk in murine skeletal muscle","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2016.01.009","article-title":"Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells","volume":"44","author":"Kuswanto","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0240","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","article-title":"The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury","volume":"85","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.cyto.2022.155891_b0245","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.aal3589","article-title":"Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development","volume":"359","author":"Vainchtein","year":"2018","journal-title":"Science"},{"issue":"388\u2013403","key":"10.1016\/j.cyto.2022.155891_b0250","article-title":"Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity","volume":"182","author":"Nguyen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2022.155891_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009027","article-title":"Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling","volume":"16","author":"Still","year":"2020","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.cyto.2022.155891_b0260","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ni.2045","article-title":"Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity","volume":"12","author":"Chang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0265","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20110079","article-title":"Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection","volume":"209","author":"Wills-Karp","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0270","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.1201224","article-title":"Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway","volume":"189","author":"Hsu","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0275","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.immuni.2016.10.031","article-title":"Perinatal activation of the Interleukin-33 pathway promotes type 2 immunity in the developing lung","volume":"45","author":"de Kleer","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0280","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65614","article-title":"IL-33 promotes innate lymphoid cell-dependent IFN-gamma production required for innate immunity to Toxoplasma gondii","volume":"10","author":"Clark","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.cyto.2022.155891_b0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6259","article-title":"Cellular context of IL-33 expression dictates impact on anti-helminth immunity","volume":"5","author":"Hung","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0290","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ajpath.2020.11.004","article-title":"Myeloid-derived IL-33 limits the severity of dextran sulfate sodium-induced colitis","volume":"191","author":"Hung","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"1624\u201337","key":"10.1016\/j.cyto.2022.155891_b0295","article-title":"IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation","volume":"144","author":"Allinne","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.012","article-title":"Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation","volume":"55","author":"Bessa","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2022.155891_b0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.20150894","article-title":"IL-33 amplifies an innate immune response in the degenerating retina","volume":"213","author":"Xi","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0310","doi-asserted-by":"crossref","first-page":"34255","DOI":"10.1038\/srep34255","article-title":"Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells","volume":"6","author":"Gautier","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2022.155891_b0315","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41467-018-05485-x","article-title":"Chromatin regulates IL-33 release and extracellular cytokine activity","volume":"9","author":"Travers","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2018.08.009","article-title":"Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization","volume":"111","author":"He","year":"2018","journal-title":"Cytokine."},{"key":"10.1016\/j.cyto.2022.155891_b0325","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion","volume":"21","author":"Hatzioannou","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0330","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3389\/fimmu.2019.02228","article-title":"Cre-loxP reporter mouse reveals stochastic activity of the Foxp3 promoter","volume":"10","author":"Bittner-Eddy","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0335","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149336","article-title":"Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease","volume":"131","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2022.155891_b0340","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0345","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0350","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0355","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2014.02.002","article-title":"Alternaria-derived serine protease activity drives IL-33 mediated asthma exacerbations","volume":"134","author":"Snelgrove","year":"2014","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0360","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0365","doi-asserted-by":"crossref","DOI":"10.1111\/all.13158","article-title":"Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium","author":"Uchida","year":"2017","journal-title":"Allergy"},{"issue":"739\u201351","key":"10.1016\/j.cyto.2022.155891_b0370","article-title":"HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33","volume":"47","author":"Osbourn","year":"2017","journal-title":"Immunity."},{"key":"10.1016\/j.cyto.2022.155891_b0375","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/cea.12718","article-title":"The challenge of measuring IL-33 in serum using commercial ELISA: lessons from asthma","volume":"46","author":"Ketelaar","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cyto.2022.155891_b0380","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/annrheumdis-2015-208557","article-title":"Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjogren syndrome: comparison of different kits","volume":"75","author":"Riviere","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2022.155891_b0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.33393\/jcb.2021.2327","article-title":"Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?","volume":"10","author":"Erfurt","year":"2021","journal-title":"J. Circ. Biomark."},{"key":"10.1016\/j.cyto.2022.155891_b0390","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaci.2016.03.056","article-title":"IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells","volume":"138","author":"Galand","year":"2016","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"1262\u201375","key":"10.1016\/j.cyto.2022.155891_b0395","article-title":"Mechanical skin injury promotes food anaphylaxis by driving intestinal mast cell expansion","volume":"50","author":"Leyva-Castillo","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0400","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20161982","article-title":"Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury","volume":"214","author":"Gadani","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088742","article-title":"The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33","volume":"9","author":"Thierry","year":"2014","journal-title":"PLoS. One."},{"key":"10.1016\/j.cyto.2022.155891_b0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002365","article-title":"IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model","volume":"14","author":"Xu","year":"2017","journal-title":"PLoS. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0415","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10020-021-00288-1","article-title":"Rapid systemic surge of IL-33 after severe human trauma: a prospective observational study","volume":"27","author":"Sundnes","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0420","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/all.12309","article-title":"IL-33 is a mediator rather than a trigger of the acute allergic response in humans","volume":"69","author":"Fux","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.cyto.2022.155891_b0425","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1073\/pnas.1601914113","article-title":"Alternative splicing of interleukin-33 and type 2 inflammation in asthma","volume":"113","author":"Gordon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0430","article-title":"Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease","volume":"6","author":"Katz-Kiriakos","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cyto.2022.155891_b0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"Luthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155891_b0440","doi-asserted-by":"crossref","first-page":"19420","DOI":"10.1074\/jbc.M901744200","article-title":"Interleukin-33 is biologically active independently of caspase-1 cleavage","volume":"284","author":"Talabot-Ayer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2022.155891_b0445","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbrc.2009.12.107","article-title":"Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation","volume":"391","author":"Ali","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0450","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41590-021-01011-2","article-title":"Environmental allergens trigger type 2 inflammation through ripoptosome activation","volume":"22","author":"Brusilovsky","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006659","article-title":"A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma","volume":"13","author":"Smith","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006925","article-title":"Rare coding variants pinpoint genes that control human hematological traits","volume":"13","author":"Mousas","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0465","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","article-title":"cIAPs block Ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms","volume":"43","author":"Feoktistova","year":"2011","journal-title":"Mol. Cell."},{"key":"10.1016\/j.cyto.2022.155891_b0470","doi-asserted-by":"crossref","first-page":"E2891","DOI":"10.1073\/pnas.1507393112","article-title":"AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites","volume":"112","author":"Kim","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0475","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2012.11.028","article-title":"Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology","volume":"131","author":"Grotenboer","year":"2013","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0480","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng.323","article-title":"Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction","volume":"41","author":"Gudbjartsson","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0485","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ng.888","article-title":"Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations","volume":"43","author":"Torgerson","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0490","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2830","article-title":"A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations","volume":"46","author":"Bonnelykke","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41588-017-0014-7","article-title":"Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks","volume":"50","author":"Demenais","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cyto.2022.155891_b0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2020.04.051","article-title":"Phenotypic and functional translation of IL33 genetics in asthma","volume":"147","author":"Ketelaar","year":"2021","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0505","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","article-title":"Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial","volume":"9","author":"Rabe","year":"2021","journal-title":"Lancet. Respir. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0510","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.4049\/jimmunol.1600611","article-title":"IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis","volume":"197","author":"Johnston","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0515","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0520","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0525","article-title":"Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials","author":"Kosloski","year":"2021","journal-title":"Clin. Transl. Sci"},{"key":"10.1016\/j.cyto.2022.155891_b0530","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131347","article-title":"Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy","volume":"4","author":"Chinthrajah","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.cyto.2022.155891_b0535","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cyto.2022.155891_b0540","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhlen","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cyto.2022.155891_b0545","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cyto.2022.155891_b0550","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41590-021-00969-3","article-title":"Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells","volume":"22","author":"Cupovic","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0555","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41467-021-25057-w","article-title":"Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment","volume":"12","author":"Ring","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0560","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1187","article-title":"Blockade of IL-33 signalling attenuates osteoarthritis","volume":"9","author":"He","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0565","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2017.01.071","article-title":"First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment","volume":"18","author":"Saluzzo","year":"2017","journal-title":"Cell. Rep."},{"key":"10.1016\/j.cyto.2022.155891_b0570","doi-asserted-by":"crossref","first-page":"15327","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155891_b0575","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155891_b0580","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4049\/jimmunol.2000181","article-title":"Group 2 Innate Lymphoid Cells Must Partner with the Myeloid-Macrophage Lineage for Long-Term Postviral Lung Disease","volume":"205","author":"Wu","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/intimm\/dxr006","article-title":"Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation","volume":"23","author":"Louten","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2022.155891_b0590","doi-asserted-by":"crossref","first-page":"18052","DOI":"10.1038\/s41598-018-36440-x","article-title":"IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation","volume":"8","author":"Hiraishi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2022.155891_b0595","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jid.2018.07.023","article-title":"Hypo-osmotic stress drives IL-33 production in human keratinocytes-an epidermal homeostatic response","volume":"139","author":"Pietka","year":"2019","journal-title":"J. Invest. Dermatol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:29:56Z","timestamp":1778581796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":119,"alternative-id":["S1043466622001004"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155891","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155891"}}